Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Short/Acting Psychedelics Recent news which mentions Short/Acting Psychedelics Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates October 13, 2023 Tickers CYBN DMTTF Tags News DMTTF Penny Stocks From Benzinga Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety August 28, 2023 Tickers CYBN DMTTF Tags Penny Stocks DMTTF News From Benzinga Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change July 05, 2023 Tickers DMTTF Tags DMTTF News Guidance From Benzinga Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable March 08, 2023 Tickers DMTTF Tags Psychedelics Benzinga Psychedelic/Assisted Therapies From Benzinga Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial February 15, 2023 Tickers DMTTF Tags Management DMT Entities Short/Acting Psychedelics From Benzinga Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents February 01, 2023 Tickers DMTTF Tags Penny Stocks News DMTTF From Benzinga Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings January 25, 2023 Tickers DMTTF Tags Short/Acting Psychedelics DMT Entities Psychedelics From Benzinga This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out October 31, 2022 Tickers DMT DMTTF Tags George Tziras Markets Market News From Benzinga This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More October 19, 2022 Tickers DMTTF Tags Legal General Short/Acting Psychedelics From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.